Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 0 | 1 | 0 | 0 |
| Receivables | N/A | N/A | 1 | 0 | 0 |
| Inventories | 1 | 1 | N/A | 0 | 0 |
| TOTAL | $1 | $1 | $2 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 37 | N/A | N/A |
| Intangibles | 65 | 65 | 193 | 0 | 0 |
| TOTAL | $65 | $65 | $230 | $N/A | $N/A |
| Total Assets | $65 | $65 | $232 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accrued Expenses | 19 | 18 | N/A | 0 | 0 |
| TOTAL | $35 | $34 | $N/A | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 2,112 | 0 | 0 |
| TOTAL | $N/A | $N/A | $2,112 | $N/A | $N/A |
| Total Liabilities | $35 | $34 | $2,112 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,593 | N/A | 54,593 | 54,593 | 54,593 |
| Common Shares | 55 | 55 | 55 | 0 | 0 |
| Retained earnings | -25 | -23 | -30,550 | 0 | 0 |
| TOTAL | $30 | $31 | $-1,880 | $0 | $0 |
| Total Liabilities And Equity | $65 | $65 | $232 | $0 | $0 |